Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
NEOGENOMICS INC | Chief Legal Officer | Common Stock | 147K | $2.71M | $18.39 | Mar 1, 2022 | Direct |
Vaxcyte, Inc. | Director | Common Stock | 7.18K | $524K | $73.00 | Jun 6, 2024 | Direct |
Arcutis Biotherapeutics, Inc. | Director | Common Stock | 18.8K | $151K | $8.01 | Jun 14, 2024 | Direct |
NEOGENOMICS INC | Chief Legal Officer | Stock Option (Right to Buy) | 103K | Mar 1, 2022 | Direct | ||
CytomX Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 38K | May 15, 2024 | Direct | ||
Arcutis Biotherapeutics, Inc. | Director | Stock Option (right to buy) | 27.1K | Jun 14, 2024 | Direct | ||
Vaxcyte, Inc. | Director | Stock Option (right to buy) | 7.25K | Jun 6, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ARQT | Arcutis Biotherapeutics, Inc. | Jun 14, 2024 | 2 | $0 | 4 | Jun 18, 2024 | Director |
PCVX | Vaxcyte, Inc. | Jun 6, 2024 | 2 | $0 | 4 | Jun 10, 2024 | Director |
PCVX | Vaxcyte, Inc. | Jun 3, 2024 | 3 | -$1.23M | 4 | Jun 5, 2024 | Director |
CTMX | CytomX Therapeutics, Inc. | May 15, 2024 | 1 | $0 | 4 | May 17, 2024 | Director |
CTMX | CytomX Therapeutics, Inc. | Jun 14, 2023 | 1 | $0 | 4 | Jun 16, 2023 | Director |
PCVX | Vaxcyte, Inc. | Jun 13, 2023 | 2 | $0 | 4 | Jun 15, 2023 | Director |
ARQT | Arcutis Biotherapeutics, Inc. | May 31, 2023 | 2 | $0 | 4 | Jun 2, 2023 | Director |
CTMX | CytomX Therapeutics, Inc. | Jun 15, 2022 | 1 | $0 | 4 | Jun 17, 2022 | Director |
ARQT | Arcutis Biotherapeutics, Inc. | Jun 1, 2022 | 2 | $0 | 4 | Jun 3, 2022 | Director |
PCVX | Vaxcyte, Inc. | Jun 1, 2022 | 2 | $0 | 4 | Jun 3, 2022 | Director |
NEO | NEOGENOMICS INC | Mar 1, 2022 | 2 | $0 | 4 | Mar 3, 2022 | Chief Legal Officer |
NEO | NEOGENOMICS INC | Dec 31, 2021 | 1 | $5.54K | 5 | Feb 8, 2022 | Chief Legal Officer |
NEO | NEOGENOMICS INC | Dec 30, 2021 | 1 | $0 | 4 | Dec 30, 2021 | Chief Legal Officer |
NEO | NEOGENOMICS INC | Aug 17, 2021 | 2 | $0 | 4 | Aug 19, 2021 | Chief Legal Officer |
NEO | NEOGENOMICS INC | Aug 17, 2021 | 0 | $0 | 3 | Aug 19, 2021 | Chief Legal Officer |
CTMX | CytomX Therapeutics, Inc. | Jun 16, 2021 | 1 | $0 | 4 | Jun 17, 2021 | Director |
ARQT | Arcutis Biotherapeutics, Inc. | Jun 9, 2021 | 1 | $0 | 4 | Jun 11, 2021 | Director |
PCVX | Vaxcyte, Inc. | Jun 2, 2021 | 1 | $0 | 4 | Jun 3, 2021 | Director |